Amarogentin promotes osteoblast differentiation in oestrogen-deficiency-induced osteoporosis rats by modulating the Nrf-2/MAPK/ERK signalling pathway.

Li, Sirui; Li, Xianlong; He, Feng; Jiao, Rui; Zhang, Song; Li, Zhihua

Li, Sirui; Li, Xianlong; He, Feng; Jiao, Rui; Zhang, Song; Li, Zhihua.

Afiliación

Li S; The Second Clinical Medical College of Dalian Medical University, Dalian, China.
Li X; The Second Clinical Medical College of Dalian Medical University, Dalian, China.
He F; The Second Clinical Medical College of Dalian Medical University, Dalian, China.
Jiao R; Clinical Medical College of Yangzhou University, Yangzhou, China.
Zhang S; The Second Clinical Medical College of Dalian Medical University, Dalian, China.
Li Z; Department of Orthopaedics, Xiaogan Central Hospital, Xiaogan, China.

Arch Med Sci ; 19(2): 452-457, 2023.

Article en En | MEDLINE | ID: mdl-37034504

Palabras clave

amarogentin; inflammation; oestrogen; osteoblast; osteoporosis; ovary

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Arch Med Sci Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google